Found 0 matching trials
Named Patient Program With Rotigotine Transdermal System N/A The named patient program will allow investigators to supply rotigotine tra...
Show More Learn More & Join Trial
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome PHASE2 This was a multicenter, open-label, dose-escalation, Phase 2A study with mu...
Show More Learn More & Join Trial
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients PHASE4 The purpose of this study was to show superiority of Rotigotine over placeb...
Show More Learn More & Join Trial
A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers PHASE1 This is a randomized, open-label, 2-sequence, 2-treatment cross-over study ...
Show More Location
Pharmaceutical Research Associates, Inc.
Learn More & Join Trial
Treatment of Parkinson's Disease With a Transdermal Skin Patch PHASE2 Patients with Parkinson's disease are missing the chemical neurotransmitter...
Show More Location
National Institute of Neurological Disorders and Stroke (NINDS)
Learn More & Join Trial
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain PHASE4 This trial is being conducted to compare the impact of Rotigotine and Place...
Show More Learn More & Join Trial
Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease PHASE2 This is phase IIa 24-week, prospective, randomized, double-blind placebo co...
Show More Location
Santa Lucia Foundation
Learn More & Join Trial
Adhesion and Safety of Rotigexole Compared to Neupro® NA A non-inferiority open-labelled crossover randomized controlled trial, of t...
Show More Location
Multiple Locations
Learn More & Join Trial
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder PHASE2 This is a randomized, double-blind, placebo-controlled phase 2b pilot clini...
Show More Location
Virginia Commonwealth University
Learn More & Join Trial
Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms PHASE4 The primary objective of this study was to demonstrate that Rotigotine impr...
Show More Learn More & Join Trial